AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,387 | +19.7% | 802,588 | -12.1% | 0.00% | +33.3% |
Q2 2023 | $2,830 | +198.8% | 912,974 | +34.1% | 0.00% | +200.0% |
Q1 2023 | $947 | -4.3% | 681,017 | +36.9% | 0.00% | 0.0% |
Q4 2022 | $990 | -99.9% | 497,474 | +42.4% | 0.00% | -50.0% |
Q1 2022 | $1,457,000 | +50.2% | 349,320 | +72.4% | 0.00% | +100.0% |
Q4 2021 | $970,000 | +99.2% | 202,566 | +121.9% | 0.00% | 0.0% |
Q3 2021 | $487,000 | -61.8% | 91,290 | -63.4% | 0.00% | -50.0% |
Q2 2021 | $1,276,000 | -63.0% | 249,160 | -51.3% | 0.00% | -60.0% |
Q1 2021 | $3,444,000 | +677.4% | 511,752 | +348.1% | 0.01% | +400.0% |
Q3 2020 | $443,000 | -92.8% | 114,213 | -91.1% | 0.00% | -90.9% |
Q2 2020 | $6,136,000 | +785.4% | 1,289,082 | +546.9% | 0.01% | +450.0% |
Q1 2020 | $693,000 | -25.8% | 199,263 | +2.9% | 0.00% | 0.0% |
Q4 2019 | $934,000 | – | 193,736 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |